New cancer drug shows promise in early trial for advanced tumours
Disease control
Recruiting now
This early-phase study tests a new drug called CCI-001 in people with advanced solid tumours that have come back or spread. The main goals are to check the drug's safety and find the best dose. The study will also see if the drug helps shrink tumours or slow cancer growth, both a…
Phase: PHASE1 • Sponsor: PharmaMatrix Holdings Ltd • Aim: Disease control
Last updated May 08, 2026 12:03 UTC